In continuation of our Letter dated 8th November 2026 we wish to inform you that a meeting of the Board of Directors of the Company was held on Thursday, 12th November 2026 at 3:00 p.m. and has transacted the following: -1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30TH September 2026 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations ....

TEJNAKSH HEALTHCARE LIMITED Regd. Office : Shop No. 1, Shivprasad Harihar Singh Compound, Jogeshwari East, Caves Road, Pratap Nagar, Mumbai, Maharashtra - 400060 Head Office : Institute of Urology Sakri Raod, Dhule - 424001 CIN : L85100MH2008PLC179034, E-mail : Instituteofurology@gmail.com Website : www.tejnaksh.com | Tel. No. 022-27454 2311, 02562 - 245322 / 245995 Date: 12-11-2026 BSE Limited Phirozeleejeebhoy Towers, Dalal Street, Mumbai —400 001 Dear Sir/Madam. Scrip Code: 539428 Subject: Outcome of Board Meeting in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In continuation of our Letter dated 8th November, 2026 we wish to inform you that a meeting of the Board of Directors of the Company was held on Thursday, 12th November, 2026 at Shop No 1 Building Name: Shivprasad Harihar Singh Compound, Block Sector: Jogeshwari East, Road: Caves Road. Pratap Nagar -Mumbai, Maharashtra, 400060 at 3:00 p.m. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30" September 2026 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The meeting of Board of Directors commenced at 3:00 p.m. and concluded at ~ 7.00 pm This is for your information and record. Thanking you. For T]jnaksh Healthcare Limited Dr. Ashish V. Rawandale Managing Director DIN: - 02005733 Maheshwari & Co. Chartered Accountants Independent Auditor’s Review Report on Unaudited Consolidated Financial Results of Tejnaksh Healthcare Limited for the quarter and half year ended September 30, 2026 pursuant to the Regulation 33 of The Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Review Report to The Board of Directors Tejnaksh Healthcare Limited 1. We have reviewed the accompanying statement of unaudited consolidated financial results of Tejnaksh Healthcare Limited (‘hereinafter referred to as ‘the Parent’) and its subsidiaries (the parent and its subsidiaries together referred to as “the Group”) for the quarter and half year ended September 30, 2026 (the ‘Statement’), attached herewith, being submitted by the Parent pursuant to the requirements of the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Regulations”). 2. This Statement which is the responsibility of the Parent's Management and has been approved by the Parent’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting” ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 (‘the Act’) as amended, read with relevant rules issued thereunder (‘Ind AS 34') and other recognized accounting principles generally accepted in India and is in compliance with the regulations. Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review ofi nterim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent applicable. 4. The statement includes the results of the following entities: a. Holding Company: Tejnaksh Healthcare Limited b. Subsidiary: Tej Vedaant Healthcare Private Limited 5. Attention is drawn to the fact that the figures for the quarter ended September 30, 2026, as reported in the Statement, are the balancing figures between the unaudited figures for the half year ended September 30, 2026, and the published unaudited figures for the quarter ended June 30, 2026, which were subjected to limited review by the Statutory Auditors. The figures up to the end of the second quarter of financial year had only been reviewed and not subjected to audit. Office: 1302/1303, Solaris One, Vijay Nagar, Opp. Teli Gali, Andheri (East), 400069 Head office: 10-11, Third Floor; Esplanade Building, 3 A K Naik Marg, Near New Empire Cinema, Fort, CST, Mumbai 400 001 Tel.: +91-22-22077472/22072620, E-mail: vkasawa@maheshwariandco.in, Website: www.maheshwariandco.in 6. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognized accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Regulations, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Maheshwari & Co. Chartered Accountants Firm'’s Registration No.: 105834W Mermbership No.: 172133 UDIN: 26172133VTZIEH4216 Place: Mumbai Date: November 12,2026 TEJNAKSH HEALTHCARE LIMITED Regd. Office : Shop No. 1, Shivprasad Harihar Singh Compound, Jogeshwari East, Caves Road, Pratap Nagar, Mumbai, Maharashtra - 400060 Head Office : Institute of Urology Sakri Raod, Dhule - 424001 CIN : L85100MH2008PLC179034, E-mail : Instituteofurology@gmail.com Website : www.tejnaksh.com | Tel. No. 022-27454 2311, 02562 - 245322 / 245995 TEJNAKSH HEALTHCARE LIMITED (CIN:LB5100MH2008PLC179034) Consolidated Balance Sheet as at September 30, 2026 All amounts are in Indian Rupees lakhs ASSETS Non-Current Assets Property, Plant and Equipment 1,789.24 1,829.30 G Oo to hd ew ri Il nl t angible Assets 147 0. 96 31 168 0. 97 50 Intangible Assets Under Development 187.25 169.25 Right-of-use assets 1820 2427 Financial Assets » Investments 001 0.01 Other Financial Assets 378.37 22293 O It nh ce or m eN o Tn a- xC u Asr sr ee tn st (A Ns es te )t s 58 24 41 3 580 .. 28 76 Total Non-Current Assets 2,582.45 247454 Currentassets Inventories 89.24 83.17 Financial Assets Trade Receivables 23844 21753 Cash and Cash Equivalents 183.63 195.00 Bank Balances Other than above 17.80 7.74 Other CO ut rh re er n tF i An sa sn ec ti sa l Assets 116 .. 57 09 26 0. 46 40 Total Current Assets 547.60 530.48 TOTAL ASSETS 3,130.05 3,005.02 EQUITY AND LIABILITIES Equity Equity Share capital 1,015.68 1,015.68 Other Equity 1,783.62 1,699.16 Equity attributable to Owners of the Company 2,799.30 2,714.84 Non Controlling Interest 55.37 49.44 Total Equity 2,854.67 2,764.28 Liabilities Non Current Liabilities Financial Liabilities Borrowings - - Lease 7.03 13.66 Other financial liabilities 385 007 Non Current Provision 1474 14.20 Deferred Tax liabilities (Net) 150.20 14640 ‘ToO tt alh e Nr o N no Cn u C ru rr er ne tn t L iL ai ba ib li il tit ii ee ss 1750 .. 91 53 1773 .. 96 63 Current Liabilities Financial Liabilities Borrowings - - TL rea as de e L Pi aa ybi al bi lt ei ses 1227 1096 TTo ot ta al l O Ou ut ts st ta an nd di in ng g d du ue es s o off CM ri ec dr io t oa rn sd oS tm ha el rl tE hn at ne r Mp ir ci rs oe s a nd Small 560. 47 12 230 .5 43 4 E [Showing first 8,000 characters — download PDF for full document]